[Federal Register Volume 61, Number 234 (Wednesday, December 4, 1996)]
[Notices]
[Pages 64358-64359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-30787]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute of Allergy and Infectious Diseases; Notice of
Meetings: National Advisory Allergy and Infectious Diseases Council;
Acquired Immunodeficiency Syndrome Subcommittee; Allergy and Immunology
Subcommittee; Microbiology and Infectious Diseases Subcommittee
Pursuant to Pub. L. 92-463, notice is hereby given of the meeting
of the National Advisory Allergy and Infectious Diseases Council,
National Institute of Allergy and Infectious Diseases, and its
subcommittees on January 23-24, 1997. Meetings of the Council, NAAIDC
Allergy and Immunology Subcommittee, NAAIDC Microbiology and Infectious
Diseases Subcommittee and the NAAIDC Acquired Immunodeficiency Syndrome
Subcommittee will be held at the National Institutes of Health,
Building 31C, Bethesda, Maryland.
The meeting of the full Council will be open to the public on
January 23 in Conference Room 10 from approximately 1 p.m. until 3:30
p.m. for opening remarks of the Institute Director, discussion of
procedural matters, Council business, and a report from the Institute
Director which will include a discussion of budgetary matters. The
primary program will include a discussion of the On-Line Review Pilot
Program, an overview of reinvention and review issues being undertaken
within the Division of Research Grants, and a presentation on emerging
infectious diseases.
On January 24 the meetings of the NAAIDC Allergy and Immunology
Subcommittee and NAAIDC Microbiology and Infectious Diseases
Subcommittee will be open to the public from 8:30 a.m. until
adjournment. The subcommittees will meet in Building 31C, conference
rooms 9 and 10 respectively.
The meeting of the NAAIDC Acquired Immunodeficiency Syndrome
Subcommittee will be open to the public from 8 until adjournment, on
January 24. The subcommittee will meet in Conference Rooms E1/E2 at the
Natcher Building.
In accordance with the provisions set forth in secs. 552b(c)(4) and
552b(c)(6), Title 5, U.S.C. and sec. 10(d) of Pub. L. 92-463, the
meeting of the NAAIDC Acquired Immunodeficiency Syndrome Subcommittee,
NAAIDC Allergy and Immunology Subcommittee and the NAAIDC Microbiology
and Infectious Diseases Subcommittee will be closed to the public for
approximately four hours for review, evaluation, and discussion of
individual grant applications. It is anticipated that this will occur
from 8:30 a.m. until approximately 1 p.m. on January 23, in conference
rooms 8, 9 and 10 respectively. The meeting of the full Council will be
closed from 4 p.m. until recess on January 23 for the review,
discussion, and evaluation of individual grant applications. These
applications and the discussions could reveal confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the
applications, disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Ms. Claudia Goad, Committee Management Officer, National Institute
of Allergy and Infectious Diseases, Solar Building, Room 3C26, National
Institutes of Health, Bethesda, Maryland 20892, 301-496-7601, will
provide a summary of the meeting and a roster of committee members upon
request. Individuals who plan to attend and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should contact Ms. Goad in advance of the meeting.
Dr. Lawrence Deyton, Acting Director, Division of Extramural
Activities, NIAID, NIH, Solar Building, Room 3C20, 6003 Executive
Boulevard, Rockville, Maryland 20892, telephone 301-496-7291, will
provide substantive program information.
(Catalog of Federal Domestic Assistance Program Nos. 93.855
Immunology, Allergic and Immunologic Diseases Research, 93.856,
[[Page 64359]]
Microbiology and Infectious Diseases Research, National Institutes
of Health)
Dated: November 25, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 96-30787 Filed 12-3-96; 8:45 am]
BILLING CODE 4140-01-M
